Showing 38,361 - 38,380 results of 100,123 for search '(( 5 nm decrease ) OR ( 5 ((step decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 1.58s Refine Results
  1. 38361

    Table_1_BNP as a New Biomarker of Cardiac Thyroid Hormone Function.DOCX by Kaihao Wang (9100646)

    Published 2020
    “…Myocardial BNP mRNA was increased 2.5-fold in Hypo rats and its expression was decreased to normal values by 14 days of T3 treatment. …”
  2. 38362
  3. 38363
  4. 38364

    Nutritional profile of patients in a multidisciplinary treatment program for severe obesity and preoperative bariatric surgery by Fernanda Cristina Carvalho Mattos MAGNO (6380201)

    Published 2021
    “…It was observed that in the 5th appointment more than 50% of the patients underwent six meals a day. …”
  5. 38365

    Blindness and Glaucoma: A Multicenter Data Review from 7 Academic Eye Clinics by Luca Rossetti (711357)

    Published 2015
    “…During follow-up the IOP decreased by 14% in these eyes but MD deteriorated by 1.1±3.5 dB/year, which was 5-fold higher than controls (0.2±1.6 dB/year). …”
  6. 38366
  7. 38367
  8. 38368

    Data_sheet_1_Therapeutic effect of psilocybin in addiction: A systematic review.docx by Pim B. van der Meer (9606147)

    Published 2023
    “…In a pilot study (n = 10), the percentage of heavy drinking days decreased significantly between baseline and weeks 5–12 (mean difference of 26.0, 95% CI = 8.7–43.2, p = 0.008). …”
  9. 38369

    Targeted Quantitative Proteomics Revealed Arsenite-induced Proteasomal Degradation of RhoB in Fibroblast Cells by Lok Ming Tam (4419121)

    Published 2019
    “…In addition, small GTPase signaling is known to be altered in many types of cancer. By employing a multiple-reaction monitoring (MRM)-based targeted proteomic method, we found that the protein level of RhoB was substantially decreased in IMR90 human lung fibroblast cells upon a 12-h exposure to 5 μM NaAsO<sub>2</sub>. …”
  10. 38370

    DataSheet1_Mesenchymal stem cells induce dynamic immunomodulation of airway and systemic immune cells in vivo but do not improve survival for mice with H1N1 virus-induced acute lun... by Yuan Tan (819132)

    Published 2023
    “…While MSC treatment accentuated changes in these populations, naïve B, antibody-secreting B cells, and T cells were decreased in MSC-treated animals at day 3. Compared to sham animals, IAV infection induced a significant 5.5-fold increase in BAL total cell counts, including CD4<sup>+</sup> and CD8<sup>+</sup> T cells, CD19<sup>+</sup> B cells, CD11b + Ly6G + neutrophils, and CD11b + Ly6C + monocytes. …”
  11. 38371

    Auditory phenotype and immunohistochemical analysis of Fhod3-TG mice. by Ely Cheikh Boussaty (17471493)

    Published 2024
    “…The survival rate of OHC in TG mice at the basal turn cochlea was significantly decreased compared to the WT control (WT vs TG (%): (IHC)100 vs 100 at apical turn (Api), 98.7± 0.95 vs 97.7±1.51 at middle turn (Mid), 94.7±2.24 vs 85.9±6.90 at basal turn (Base); (OHC) 97.1±1.16 vs 95±2.56 at Api, 96.8±0.36 vs 96.5±1.42 at Mid, 95.6±0.64 vs 75.93±8.98 at base, p* = 0.0233 by two-way ANOVA followed by a Tukey post-hoc test) (WT vs TG in the basal OHC (%): 95.6±0.64 vs 75.93±8.98, <i>p*</i> = 0.023 by Mann-Whitney U test, n = 4). …”
  12. 38372

    Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

    Published 2023
    “…Background<p>To investigate whether ivermectin inhibits SARS-CoV-2 proliferation in patients with mild-to-moderate COVID-19 using time to a negative COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) test.…”
  13. 38373

    Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

    Published 2023
    “…Background<p>To investigate whether ivermectin inhibits SARS-CoV-2 proliferation in patients with mild-to-moderate COVID-19 using time to a negative COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) test.…”
  14. 38374

    Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

    Published 2023
    “…Background<p>To investigate whether ivermectin inhibits SARS-CoV-2 proliferation in patients with mild-to-moderate COVID-19 using time to a negative COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) test.…”
  15. 38375

    Table_1_BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists.docx by Andrés Noé (3620534)

    Published 2023
    “…Samples from 29 children, aged 5-11 years, before and 28 days after a second BNT162b2 vaccination were analysed (V2 + 28). …”
  16. 38376

    DataSheet_1_BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists.zip by Andrés Noé (3620534)

    Published 2023
    “…Samples from 29 children, aged 5-11 years, before and 28 days after a second BNT162b2 vaccination were analysed (V2 + 28). …”
  17. 38377
  18. 38378
  19. 38379

    Evolution over time of Pao/Fioratio following PV measurements and during a control period by Antoine Roch (64984)

    Published 2011
    “…Data are expressed as percentage increase or decrease in Pao/Fioratio at 5, 15, 30 and 60 minutes as compared with values before PV measurement or the control period. …”
  20. 38380

    A focal perturbation of the MET channels gives rise to an well-formed and periodic coda. by Yizeng Li (3159243)

    Published 2016
    “…<p>A: Normalized temporal displacement of the BM at 2.5 mm for a cochlea with 12% focal activity increment on the MET channel at 2.5 mm. …”